Recently I had the wonderful opportunity to visit the Wellcome Trust Library in London and review the archives of Elizabeth Brice and the UK chapter of the Alliance for Cannabis Therapeutics (ACT). A history student from Bristol University alerted me to the existence of these archives. He was writing his undergraduate dissertation on the role of patients in changing the attitudes toward medical cannabis in the United Kingdom so it is no surprise that he focused on Elizabeth. For much of the 1990s Liz was THE face of medical cannabis in Britain. She was a powerful voice for the issue and she was also an MS patient.
Multiple sclerosis (MS) is quite prevalent in Britain. At one time there was a theory that MS tended to cluster in cold climates. Whether that is true or not I don’t know but it does seem to me that most MS patients I have had the pleasure to know have been from northern climes. Elizabeth read that cannabis could help her MS and after some careful trials she determined that it was, indeed, very helpful. She set out to help others and almost single-handedly turned the tide of public opinion. She also became friends with a fellow named Geoffrey Guy who would establish GW Pharmaceuticals in England. Dr. Guy was determined to establish a cannabis-based medicine that would be available through the conventional channels of doctor-patient-pharmacist. He succeeded in developing Sativex. Liz was among the first to use the drug and found it quite helpful.
Sativex has been controversial but a recent study in Italy found it to be helpful for MS patients. Here is the link: https://multiplesclerosisnewstoday.com/2018/06/29/sativex-relieves-pain-multiple-sclerosis-italian-study/. Liz would be happy to read this report. Unfortunately she died in 2011 at the age of 54, the same age as Robert was when he died (in 2001). These heroic patients get too little credit for today’s booming green rush. I’ll be writing more about Elizabeth and the other brave souls who were the true pioneers of medical cannabis.